Corporate Actions & Capital Structure › Sub-category

Buyback

16 articles
Several Indian companies are returning capital to shareholders through dividends and buybacks, reflecting strong financial performance and balance sheet strength. Zydus Lifesciences reported robust Q4 results, including a 16% revenue increase, and announced a dividend and a ₹11 billion share buyback at ₹1,150 per share. Meanwhile, Bajaj Auto, celebrating its centenary, proposed a significant ₹5,633 crore buyback at ₹12,000 per share alongside a substantial dividend payout. Other companies, such as Sarla Performance Fibers, Dhanuka Agritech, Rolex Rings, CMS Info Systems, and CyberTech Systems, also approved share buyback programs, indicating a broader trend of companies prioritizing shareholder returns amid positive earnings momentum.
Nvidia Q1 FY27 Beats Estimates, $80B Buyback
Nvidia reported FY2027 Q1 adjusted EPS $1.87 and revenue $81.62 bn, beating consensus estimates of $1.77 EPS and $79.19 bn revenue. GAAP EPS was $2.39; adjusted gross margin reached 75% (up 14.2 bps Y
Nvidia Beats Q1 Forecast, Launches $80B Buyback
Nvidia reported FY2027 Q1 adjusted EPS $1.87 and revenue $81.62 bn, beating analyst forecasts of $1.77 EPS and $79.19 bn revenue. The company issued Q2 revenue guidance of $91 bn ±2%, surpassing the c
Matrimony.com Q4 FY26 Billing Up 9.9% YoY
• Matrimony.com reported Q4 FY26 consolidated billing growth of 9.9% YoY to ₹126.1 crore and revenue growth of 7.9% YoY to ₹116.8 crore. • The company completed a ₹58.5 crore share buyback in Q4 and e
Onward Technologies ₹18 Crore Equity Share Buyback
Onward Technologies Limited announces a tender offer buyback of up to 5,48,780 equity shares at ₹328 per share for an aggregate consideration not exceeding ₹18 crores. The buyback offers 39 shares for
TeamLease Q4 EBITDA Up 8% QoQ, Announces ₹600 Crore Buyback
TeamLease reported Q4FY26 consolidated results with EBITDA up 8% QoQ to ₹46.0 crore and PBT up 5% QoQ to ₹51.6 crore, excluding one-time items. Full-year FY26 performance showed EBITDA growth of 14% Y
TeamLease FY26 Net Profit Up 33% to ₹141.38 Crore
TeamLease reported consolidated FY26 net profit of ₹141.38 crore, up 33% YoY, with revenue growth of 6% to ₹11,859.38 crore. The board approved a ₹238 crore buyback at ₹1,600 per share, representing 8
Onward Technologies ₹18 Crore Equity Share Buyback
Onward Technologies Limited proposes to buy back up to 5,48,780 equity shares at ₹328 per share for an aggregate amount not exceeding ₹18 crores through a tender offer. The buyback, approved by the Bo
TeamLease Q4 FY26 Net Profit ₹46.05 Crore, Announces ₹238 Crore Buyback
TeamLease approved audited standalone and consolidated financial results for Q4 and full year FY26, reporting consolidated net profit of ₹46.05 crore for the quarter. Board approved buyback of 14.88 l
Zydus Lifesciences Promoters Intend to Participate in Buyback
Zydus Lifesciences intimates exchanges of its promoters' intention to participate in the company's ongoing share buyback. The buyback is for up to 95.65 lakh shares (0.95% equity) at ₹1,150 per share,
Dhanuka Agritech Q4 Net Profit Rises 29.5% YoY
Dhanuka Agritech reported Q4 FY26 net profit of ₹97.77 crore, up 29.50% YoY, with revenue growth of 9.35% to ₹483.34 crore. Board approved buyback of 500,000 shares at ₹1,400 per share (₹70 crore tota
CMS Info Systems Q4 FY26 Earnings Call Transcript
CMS Info Systems held its Q4 FY26 earnings call to discuss a challenging year impacted by a Rs.150 crore revenue shortfall from SBI contract delays, ATM market contraction, and weak consumption. The c
Sarla Performance Fibers ₹44 Crore Equity Buyback Offer
Sarla Performance Fibers announces tender offer to buy back up to 40 lakh equity shares at ₹110 per share for an aggregate ₹44 crore. Buyback reserved 15% for small shareholders and excludes promoter
Zydus Lifesciences Q4 Revenue Up 16% YoY, Announces Dividend and Buyback
Zydus Lifesciences reported Q4 FY26 revenue growth of 16.2% YoY to ₹75.87 billion and EBITDA growth of 20.2% to ₹25.54 billion. The Board recommended a 100% dividend for FY26 and approved a share buyb
Zydus Lifesciences Q4 Revenue Up 16% YoY
Zydus Lifesciences reported Q4 FY26 revenue of ₹75,870 mn, a 16% YoY growth, with EBITDA margin expanding 110 bps to 33.7%. The India branded formulations business grew 15% YoY, outperforming the mark
Zydus Lifesciences Approves ₹1,100 Crore Share Buyback
Zydus Lifesciences board approved a ₹1,100 crore share buyback of up to 0.95% equity at ₹1,150 per share via tender offer. The buyback size represents 5.16% and 3.84% of standalone and consolidated ne
Dhanuka Agritech Approves ₹70 Crore Buyback, 100% Dividend
• Board approved audited FY26 results with net profit of ₹287.23 crore and a final dividend of ₹2 per share (100%). • Approved a ₹70 crore buyback of 500,000 shares at ₹1,400 per share via tender offe